Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 3
1998 1
1999 1
2000 1
2003 1
2009 2
2010 8
2011 9
2012 10
2013 16
2014 14
2015 20
2016 21
2017 23
2018 22
2019 26
2020 38
2021 42
2022 44
2023 59
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
Long COVID or post COVID-19 syndrome.
Lechner-Scott J, Levy M, Hawkes C, Yeh A, Giovannoni G. Lechner-Scott J, et al. Mult Scler Relat Disord. 2021 Oct;55:103268. doi: 10.1016/j.msard.2021.103268. Epub 2021 Sep 17. Mult Scler Relat Disord. 2021. PMID: 34601388 Free PMC article. No abstract available.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, Banwell BL, Barkhof F, Corboy JR, Correale J, Fujihara K, Graves J, Harnegie MP, Hemmer B, Lechner-Scott J, Marrie RA, Newsome SD, Rocca MA, Royal W 3rd, Waubant EL, Yamout B, Cohen JA. Solomon AJ, et al. Among authors: lechner scott j. Lancet Neurol. 2023 Aug;22(8):750-768. doi: 10.1016/S1474-4422(23)00148-5. Lancet Neurol. 2023. PMID: 37479377 Review.
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
Roos I, Hughes S, McDonnell G, Malpas CB, Sharmin S, Boz C, Alroughani R, Ozakbas S, Buzzard K, Skibina O, van der Walt A, Butzkueven H, Lechner-Scott J, Kuhle J, Terzi M, Laureys G, Van Hijfte L, John N, Grammond P, Grand'Maison F, Soysal A, Jensen AV, Rasmussen PV, Svendsen KB, Barzinji I, Nielsen HH, Sejbæk T, Prakash S, Stilund MLM, Weglewski A, Issa NM, Kant M, Sellebjerg F, Gray O, Magyari M, Kalincik T; MSBase Study GroupDanish MS Registry Study Group. Roos I, et al. Among authors: lechner scott j. JAMA Neurol. 2023 Aug 1;80(8):789-797. doi: 10.1001/jamaneurol.2023.1625. JAMA Neurol. 2023. PMID: 37307006
Melatonin and multiple sclerosis.
Hawkes CH, Baker MD, Pohl D, Lechner-Scott J, Levy M, Giovannoni G. Hawkes CH, et al. Among authors: lechner scott j. Mult Scler Relat Disord. 2021 Jun;51:103032. doi: 10.1016/j.msard.2021.103032. Epub 2021 May 18. Mult Scler Relat Disord. 2021. PMID: 34051443 No abstract available.
Multiple sclerosis is one disease.
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA. Giovannoni G, et al. Among authors: lechner scott j. Mult Scler Relat Disord. 2022 Jul;63:103961. doi: 10.1016/j.msard.2022.103961. Epub 2022 Jun 11. Mult Scler Relat Disord. 2022. PMID: 35714573 No abstract available.
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, White OB, Broadley S, Lechner-Scott J, Vucic S, Henderson APD, Barnett MH, Reddel SW, Brilot F, Dale RC; Australasian and New Zealand MOG Study Group. Ramanathan S, et al. Among authors: lechner scott j. J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15. J Neurol Neurosurg Psychiatry. 2018. PMID: 29142145 Free PMC article.
Is multiple sclerosis overdiagnosed?
Hawkes CH, Giovannoni G, Lechner-Scott J, Levy M, Pohl D. Hawkes CH, et al. Among authors: lechner scott j. Mult Scler Relat Disord. 2021 Jan;47:102721. doi: 10.1016/j.msard.2020.102721. Epub 2020 Dec 28. Mult Scler Relat Disord. 2021. PMID: 33602498 No abstract available.
Implications of Low-Titer MOG Antibodies.
Levy M, Yeh EA, Hawkes CH, Lechner-Scott J, Giovannoni G. Levy M, et al. Among authors: lechner scott j. Mult Scler Relat Disord. 2022 Mar;59:103746. doi: 10.1016/j.msard.2022.103746. Epub 2022 Mar 17. Mult Scler Relat Disord. 2022. PMID: 35320765 No abstract available.
322 results